Published in Br J Cancer on May 01, 1990
Is there a role for 'modified VAD' in the treatment of multiple myeloma? Ecancermedicalscience (2009) 0.75
Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med (1984) 3.06
Multiple myeloma and severe renal failure: a clinicopathologic study of outcome and prognosis in 34 patients. Medicine (Baltimore) (1987) 1.10
Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. Br J Cancer (1988) 1.09
Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients. Nouv Rev Fr Hematol (1986) 0.91
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Can preliminary screening of dyspeptic patients allow more effective use of investigational techniques? Br Med J (Clin Res Ed) (1985) 2.37
Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant (1992) 2.03
Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood (1987) 1.96
Prognostic factors in upper G.I. bleeding. Endoscopy (1986) 1.94
Transfer of computer-aided diagnosis of dyspepsia from one geographical area to another. Gut (1976) 1.57
The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. Gut (1990) 1.49
The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant (1999) 1.49
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
Ascending polyneuropathy in leptospirosis--a case study. Ann Trop Med Parasitol (1980) 1.47
Islets of Langerhans in juvenile diabetes mellitus. Clin Endocrinol (Oxf) (1973) 1.44
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood (1995) 1.43
Cyclosporin toxicity and colitis. Lancet (1988) 1.42
Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet (1992) 1.40
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36
In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med (1986) 1.36
Clinical findings, early endoscopy, and multivariate analysis in patients bleeding from the upper gastrointestinal tract. Br Med J (1977) 1.35
Macrophage clearance function and immune complex disease in New Zealand Black/White F1 hybrid mice. Clin Exp Immunol (1976) 1.30
Renal function in patients over 40 with homozygous sickle-cell disease. Br Med J (Clin Res Ed) (1981) 1.30
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.30
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29
Relationship between macrophage clearance of PVP and affinity of anti-protein antibody response in inbred mouse strains. Nature (1975) 1.24
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet (1993) 1.24
Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood (1999) 1.18
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant (2010) 1.16
Mannitol retention during diuretic treatment of barbiturate and salicylate overdosage. Q J Med (1968) 1.12
Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br J Haematol (2001) 1.10
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) (1986) 1.10
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant (2008) 1.08
Pregnancy associated aplastic anaemia: a report of five cases and review of current management. Br J Haematol (1989) 1.08
Diabetic glomerulosclerosis without diabetes mellitus--two case reports and a review of the literature. Nephrol Dial Transplant (1992) 1.07
Do the stigmata of recent haemorrhage have additional prognostic value in patients with bleeding duodenal ulcer? Scand J Gastroenterol Suppl (1988) 1.06
Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients. Nephrol Dial Transplant (1996) 1.05
Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut (1982) 1.05
The biochemical pharmacology of thromboxane synthase inhibition in man. Circulation (1985) 1.05
Child and parental acceptance of preformed metal crowns. Eur Arch Paediatr Dent (2010) 1.05
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol (2003) 1.05
Cimetidine: an advance in gastric ulcer treatment? Br Med J (1978) 1.04
Acetazolamide and sodium bicarbonate in treatment of salicylate poisoning in adults. Br Med J (1969) 1.04
Copper-resistant enteric bacteria from United Kingdom and Australian piggeries. Appl Environ Microbiol (1993) 1.02
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation (1986) 1.02
Pulmonary vascular permeability to transferrin in the pulmonary oedema of renal failure. Thorax (1987) 1.02
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia. Leukemia (2009) 1.01
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A. Bone Marrow Transplant (1992) 1.01
Potassium balance and acid-base changes in patients undergoing regular haemodialysis therapy. Br Med J (1970) 1.00
Functional hyposplenism following allogeneic bone marrow transplantation. J Clin Pathol (1995) 0.99
Hypothyroidism and renal impairment. J R Soc Med (1991) 0.99
DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412. Leukemia (2006) 0.98
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms. Br J Rheumatol (1988) 0.98
Bone marrow transplantation: current situation, complications and prevention. J Antimicrob Chemother (1995) 0.97
Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment. Leukemia (2005) 0.97
The excretion of salicylate in salicylate poisoning. Clin Sci (1971) 0.96
Erythropoietin and renal function in sickle-cell disease. Br Med J (Clin Res Ed) (1982) 0.95
A new syndrome associated with hepatocellular carcinoma. Gastroenterology (1972) 0.95
Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation. Bone Marrow Transplant (2011) 0.94
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome. Br J Haematol (2004) 0.94
Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia (1995) 0.93
A nutritional survey in the elderly: blood and urine vitamin levels. Int J Vitam Nutr Res (1975) 0.93
Effect of dialysate fluids on phagocytosis and killing by normal neutrophils. J Clin Microbiol (1987) 0.93
Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure. Diabet Med (1996) 0.91
Renal pathology in adults over 40 with sickle-cell disease. West Indian Med J (1987) 0.91
Eicosenoid biosynthesis and platelet function with advancing age. Thromb Res (1986) 0.91
O.M.G.E. International Upper Gastro-intestinal Bleeding Survey 1978-1982. Scand J Gastroenterol Suppl (1984) 0.90
Allogeneic bone marrow transplantation for systemic AL amyloidosis. Br J Haematol (1998) 0.89
Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut (1976) 0.89
Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant. Bone Marrow Transplant (2001) 0.89
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit. J Clin Oncol (1997) 0.89
Clinical impact of MRSA in a stem cell transplant unit: analysis before, during and after an MRSA outbreak. Bone Marrow Transplant (2007) 0.88
Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1996) 0.88
Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer (1994) 0.88
Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. Bone Marrow Transplant (1993) 0.87
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry. Leukemia (2010) 0.87
Glomerular function and hyperuricaemia in sickle cell disease. J Clin Pathol (1984) 0.87
Impact of the Hall technique for preformed metal crown placement on undergraduate paediatric dentistry experience. Eur J Dent Educ (2012) 0.86
Serum urate concentrations in homozygous sickle cell disease. J Clin Pathol (1981) 0.86
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion. Cytotherapy (2001) 0.86
Multiple recurring gastric erosions/aphthous ulcers). Gut (1976) 0.86
Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant (1995) 0.86
Extramedullary haemopoiesis as a cause of mediastinal lymphadenopathy in chronic myelomonocytic leukaemia. Clin Lab Haematol (1990) 0.86
Interleukin-1beta maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways. Leukemia (2004) 0.86
Topical anaesthesia for fistula cannulation in haemodialysis patients. Nephrol Dial Transplant (1988) 0.85
Thrombocytopathy in preleukaemia: association with a defect of thromboxane A2 activity. Br J Haematol (1979) 0.85
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course. Br J Haematol (1998) 0.85
Impaired peritoneal fluid drainage in nephrogenic ascites. Clin Nephrol (1981) 0.84
Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. Bone Marrow Transplant (2007) 0.84
Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk. Bone Marrow Transplant (1997) 0.84
Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia. Leukemia (2003) 0.84
Early allogeneic transplantation for refractory or relapsed acute leukaemia following remission induction with FLAG. Leukemia (1999) 0.84
Neutrophil function in patients on continuous ambulatory peritoneal dialysis. Br J Haematol (1988) 0.84
Effect of peritoneal dialysis effluent on superoxide anion production by polymorphonuclear neutrophils. Nephron (1993) 0.84
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia. Bone Marrow Transplant (2000) 0.84
The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl (1989) 0.84
Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients. Br J Haematol (1994) 0.84
Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. Gut (1985) 0.83
An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation. Cytotherapy (2000) 0.83